Rheumatoid Arthritis Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Rheumatoid Arthritis stocks.

Recent Signals

Date Stock Signal Type
2021-04-16 ARGX 1,2,3 Retracement Bearish Bearish Swing Setup
2021-04-16 ARGX Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-04-16 ARGX 20 DMA Resistance Bearish
2021-04-16 ARGX 200 DMA Support Bullish
2021-04-16 ATRS Fell Below 20 DMA Bearish
2021-04-16 ATRS Bollinger Band Squeeze Range Contraction
2021-04-16 BMY Upper Bollinger Band Walk Strength
2021-04-16 BMY Stochastic Reached Overbought Strength
2021-04-16 BMY Pocket Pivot Bullish Swing Setup
2021-04-16 CANF MACD Bearish Centerline Cross Bearish
2021-04-16 CANF 1,2,3 Pullback Bullish Bullish Swing Setup
2021-04-16 CGEN 20 DMA Support Bullish
2021-04-16 CHRS Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-04-16 CHRS 20 DMA Resistance Bearish
2021-04-16 CVM Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-04-16 CVM Crossed Above 20 DMA Bullish
2021-04-16 EBS Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-04-16 EBS 1,2,3 Retracement Bearish Bearish Swing Setup
2021-04-16 GLPG 20 DMA Support Bullish
2021-04-16 HZNP Cup with Handle Other
2021-04-16 KYMR Narrow Range Bar Range Contraction
2021-04-16 KYMR 20 DMA Support Bullish
2021-04-16 KYMR 1,2,3 Retracement Bearish Bearish Swing Setup
2021-04-16 KYMR Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-04-16 LABP Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-04-16 LXRX Expansion Breakdown Bearish Swing Setup
2021-04-16 MESO Bollinger Band Squeeze Range Contraction
2021-04-16 MESO Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-04-16 MESO Stochastic Reached Overbought Strength
2021-04-16 PCRX Expansion Breakdown Bearish Swing Setup
2021-04-16 PCRX 200 DMA Support Bullish
2021-04-16 PLX Pocket Pivot Bullish Swing Setup
2021-04-16 PLX Expansion Breakout Bullish Swing Setup
2021-04-16 PLX Upper Bollinger Band Walk Strength
2021-04-16 REGN Stochastic Reached Overbought Strength
2021-04-16 XGN 20 DMA Resistance Bearish
2021-04-16 XNCR Bearish Engulfing Bearish
2021-04-16 XNCR Fell Below 20 DMA Bearish

Recent News for Rheumatoid Arthritis Stocks

Date Stock Title
Apr 18 BMY AACR 2021 highlights Eli Lilly’s new KRAS battle; Affimed’s Natural Killer cell therapy
Apr 17 REGN 3 Cathie Wood Stocks You Can Buy at a Bargain Right Now
Apr 17 HZNP 3 Reasons to Buy Horizon Therapeutics Stock and 1 Not To
Apr 17 REGN Could Vir Biotechnology Be a Millionaire Maker Stock?
Apr 16 RIGL Is an EUA for Rigel’s COVID-19 Treatment in the Cards? Analyst Weighs In
Apr 16 REGN Vaccinating kids will be very important in getting to herd immunity: Expert
Apr 16 BMY U.S. Food and Drug Administration Approves Opdivo® (nivolumab) in Combination with Chemotherapy for Patients with Advanced or Metastatic Gastric Cancer, Gastroesophageal Junction Cancer, and Esophageal Adenocarcinoma....
Apr 16 BMY FDA approves Bristol's Opdivo as first-line gastric cancer treatment
Apr 16 BMY Latest Upgrades and Downgrades: Bristol-Myers Squibb, Splunk, Tesla
Apr 16 BMY Bristol-Myers Gastric-Cancer Treatment Cleared by FDA
Apr 16 XGN Are Institutions Heavily Invested In Exagen Inc.'s (NASDAQ:XGN) Shares?
Apr 16 REGN Pfizer CEO says a third vaccine dose is likely, Moderna updates booster shot timeline
Apr 16 HZNP Horizon Therapeutics' Tepezza shows improvement in thyroid eye disease symptoms
Apr 16 HZNP Horizon Therapeutics' Uplinza shows sustained reduction in NMOSD over 4 years
Apr 16 HZNP New Long-Term Data for UPLIZNA® (inebilizumab-cdon) in People Living with Neuromyelitis Optica Spectrum Disorder (NMOSD)
Apr 16 HZNP New Integrated Data and Follow-up Outcomes From Two TEPEZZA® (teprotumumab-trbw) Pivotal Trials Published in The Lancet Diabetes & Endocrinology
Apr 16 REGN 4 Cathie Wood Stocks That Could Deliver Bigger Gains Than Tesla
Apr 16 BMY The Smartest Stocks to Buy With $200 Right Now
Apr 15 CVM Coronavirus update: J&J vaccine pause remains, Oxford studies blood clots and COVID-19 vaccines
Apr 15 REGN More domestic medical supply manufacturing is ‘critical’ for the U.S. : Premier President

Rheumatoid arthritis (RA) is a long-term autoimmune disorder that primarily affects joints. It typically results in warm, swollen, and painful joints. Pain and stiffness often worsen following rest. Most commonly, the wrist and hands are involved, with the same joints typically involved on both sides of the body. The disease may also affect other parts of the body. This may result in a low red blood cell count, inflammation around the lungs, and inflammation around the heart. Fever and low energy may also be present. Often, symptoms come on gradually over weeks to months.While the cause of rheumatoid arthritis is not clear, it is believed to involve a combination of genetic and environmental factors. The underlying mechanism involves the body's immune system attacking the joints. This results in inflammation and thickening of the joint capsule. It also affects the underlying bone and cartilage. The diagnosis is made mostly on the basis of a person's signs and symptoms. X-rays and laboratory testing may support a diagnosis or exclude other diseases with similar symptoms. Other diseases that may present similarly include systemic lupus erythematosus, psoriatic arthritis, and fibromyalgia among others.The goals of treatment are to reduce pain, decrease inflammation, and improve a person's overall functioning. This may be helped by balancing rest and exercise, the use of splints and braces, or the use of assistive devices. Pain medications, steroids, and NSAIDs are frequently used to help with symptoms. Disease-modifying antirheumatic drugs (DMARDs), such as hydroxychloroquine and methotrexate, may be used to try to slow the progression of disease. Biological DMARDs may be used when disease does not respond to other treatments. However, they may have a greater rate of adverse effects. Surgery to repair, replace, or fuse joints may help in certain situations. Most alternative medicine treatments are not supported by evidence.RA affects about 24.5 million people as of 2015. This is between 0.5 and 1% of adults in the developed world with 5 and 50 per 100,000 people newly developing the condition each year. Onset is most frequent during middle age and women are affected 2.5 times as frequently as men. In 2013, it resulted in 38,000 deaths up from 28,000 deaths in 1990. The first recognized description of RA was made in 1800 by Dr. Augustin Jacob Landré-Beauvais (1772–1840) of Paris. The term rheumatoid arthritis is based on the Greek for watery and inflamed joints.

More about Rheumatoid Arthritis
Browse All Tags